Mitotan

Mitotan Struktur
53-19-0
CAS-Nr.
53-19-0
Bezeichnung:
Mitotan
Englisch Name:
Mitotan
Synonyma:
MITOTANE;LYSODREN;Mitotam;O,P'-DDD;2,4'-DDD;Mitotane API;CB-313;Peprin;4′-DDD;p'-DDD
CBNumber:
CB0392321
Summenformel:
C14H10Cl4
Molgewicht:
320.04
MOL-Datei:
53-19-0.mol

Mitotan Eigenschaften

Schmelzpunkt:
77-78 °C(lit.)
Siedepunkt:
405.59°C (rough estimate)
Dichte
1.3118 (rough estimate)
Brechungsindex
1.6000 (estimate)
storage temp. 
Inert atmosphere,Room Temperature
Löslichkeit
DMSO: soluble20mg/mL, clear
Aggregatzustand
powder
Farbe
white to beige
Wasserlöslichkeit
<0.1 g/100 mL at 24 ºC
Merck 
13,6237 / 13,6237
BRN 
2056007
CAS Datenbank
53-19-0(CAS DataBase Reference)
NIST chemische Informationen
Mitotane(53-19-0)
EPA chemische Informationen
o,p'-DDD (53-19-0)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xn
R-Sätze: 40
S-Sätze: 36/37
RIDADR  3249
WGK Germany  3
RTECS-Nr. KH7880000
HazardClass  6.1(b)
PackingGroup  III
HS Code  2903990002
Giftige Stoffe Daten 53-19-0(Hazardous Substances Data)
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H351 Kann vermutlich Krebs verursachen. Karzinogenität Kategorie 2 Warnung P201, P202, P281, P308+P313, P405,P501
Sicherheit
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.

Mitotan Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R40:Verdacht auf krebserzeugende Wirkung.

S-Sätze Betriebsanweisung:

S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.

Beschreibung

Mitotane is an inhibitor of steroidogenesis that suppresses the growth of adrenocortical cells. It blocks the expression of several genes that encode proteins involved in steroidogenesis and disrupts mitochondrial respiratory chain activity in human adrenocortical cells. Mitotane has anti-neoplastic actions, alone or in combination with other compounds, and suppresses cortisol synthesis, although it also has significant toxicity in the gastrointestinal tract and nervous system. It is effective against adrenocortical carcinoma and Cushing’s Syndrome in clinical trials.

Chemische Eigenschaften

Crystalline Solid

Verwenden

Mitotane is an inhibitor of steroidogenesis that suppresses the growth of adrenocortical cells. It blocks the expression of several genes that encode proteins involved in steroidogenesis and disrupts mitochondrial respiratory chain activity in human adrenocortical cells. Mitotane has anti-neoplastic actions, alone or in combination with other compounds, and suppresses cortisol synthesis, although it also has significant toxicity in the gastrointestinal tract and nervous system. It is effective against adrenocortical carcinoma and Cushing’s Syndrome in clinical trials.

Indications

Mitotane (Lysodren) produces selective atrophy of the zona fasciculata and zona reticularis, which results in a decrease in the secretion of 17-hydroxycorticosteroids. Direct inhibition of cholesterol side-chain cleavage and 11/18-hydroxylase activities has also been demonstrated.

Allgemeine Beschreibung

Colorless powder.

Air & Water Reaktionen

Insoluble in water.

Reaktivität anzeigen

Mitotan dehydrohalogenates with strong alkalis. Simple aromatic halogenated organic compounds are very unreactive; halogenated aliphatic compounds are moderately or very reactive. For both subgroups, reactivity generally decreases with increased degree of substitution of halogen for hydrogen atoms. Materials in this group are incompatible with strong oxidizing and reducing agents. Also, they are incompatible with many amines, nitrides, azo/diazo compounds, alkali metals, and epoxides.

Brandgefahr

Flash point data for Mitotan are not available. Mitotan is probably combustible.

Pharmakologie

Mitotane, a derivative of the insecticide DDT, quickly lowers the level of corticosteroids, and is metabolized in the blood and urine and used on non-operable metastatic prostate carcinomas. Synonyms of this drug are lysodren and others.

Clinical Use

Mitotane is the drug of choice for the treatment of primary adrenal carcinoma when surgery or radiation therapy is not feasible. Its effectiveness in curtailing adrenal activity is due to an action on adrenocortical mitochondria to impair cytochrome P450 steps in steroid biosynthesis. Mitotane requires metabolic transformation to exert its therapeutic action, and the differential ability of tumors to metabolize the drug may determine its clinical effectiveness. It is advised to measure serum mitotane levels and urinary free cortisol excretion to ensure adequate therapeutic concentrations. Mitotane increases circulating cholesterol by inhibiting cytochrome P450–mediated reactions and therefore contributes to the cardiovascular events that are a significant cause of mortality in untreated Cushing’s syndrome.
Mitotane, being closely related to the organochlorine insecticides, shares its inductive effects on the liver microsomal drug-metabolizing enzyme system, and its use may therefore alter the requirement for concomitantly administered drugs that are also metabolized by this pathway.

Nebenwirkungen

Mitotane is capable of inducing remission of Cushing’s disease, but only after several weeks of therapy and at the price of severe gastrointestinal distress. Moreover, more than half of patients relapse following cessation of therapy. Other side effects include lethargy, mental confusion, skin rashes, and altered hepatic function. Being a lipid-soluble substance, mitotane remains stored in body tissues for extended periods. This may account for the marked patient-to-patient variability in its therapeutic and/or toxic effects.

läuterung methode

Purify Mitotane by recrystallisation from pentane, MeOH or EtOH. It is soluble in isooctane and CCl4. [Haller et al. J Am Chem Soc 67 1600 1945, Beilstein 5 IV 1883.]

Mitotan Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Mitotan Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 294)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12468 58
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806
sales@capotchem.com China 29797 60
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21689 55
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32686 60
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
SHANDONG ZHI SHANG CHEMICAL CO.LTD
+86 18953170293
sales@sdzschem.com China 2931 58
Hebei Guanlang Biotechnology Co., Ltd.
+86-19930503282
alice@crovellbio.com China 8829 58
Xiamen AmoyChem Co., Ltd
+86-592-6051114 +8618959220845
sales@amoychem.com China 6387 58
Hubei xin bonus chemical co. LTD
86-13657291602
linda@hubeijusheng.com CHINA 22968 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58

53-19-0(Mitotan)Verwandte Suche:


  • 2,4’-dichlorophenyldichlorethane
  • 2,4'-Dichlorophenyldichlorethane
  • Benzene, 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]-
  • Ethane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-
  • Ethane, 2-(o-chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloro-
  • ethane,2,2-dichloro-1-(2-chlorophenyl)-1-(4-chlorophenyl)-
  • Khlodithan
  • NCI-C04933
  • o,p’-dichlorodiphenyldichloroethane
  • o,p'-Dichlorodiphenyldichloroethane
  • Opeprim
  • N-(3-Chloro-4-fluorophenyl)-7-Methoxy-6-(3-Morpholinopropoxy)quinazolin-4-aMine, 95+%
  • 2, 4′-DDD, 100 μg/μL in acetone
  • O,P'-DDD Solution, 100ppm
  • 2,4′-DDD Standard
  • 2,4'-DDD solution, 100ppm
  • 2-(2-CHLOROPHENYL)-2-(4-CHLOROPHENYL)-1,1-DICHLOROETHANE
  • 2,2-(2-chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane
  • 2,4'-TDE
  • (2,4'-DICHLORODIPHENYL)DICHLOROETHANE
  • 1,1-DICHLORO-2-(O-CHLOROPHENYL)-2-(P-CHLOROPHENYL)ETHANE
  • 1,1-DICHLORO-2-(2-CHLOROPHENYL)-2-(4-CHLOROPHENYL)ETHANE
  • 1,1-dichloro-2,2-bis(2,4'-dichlorophenyl)ethane
  • 1-(2-CHLOROPHENYL)-1-(4-CHLOROPHENYL)-2,2-DICHLOROETHANE
  • 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)benzene
  • O,P'-TDE
  • MITOTAN
  • CB-313
  • 'LGC' (1126)
  • 1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane
  • 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-ethan
  • 1,1-Dichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane
  • 2,2,o,p-tetrachloroethylidenebisbenzene
  • 2,4'-DDD PESTANAL, 250 MG (2-(2-CHLOROPH
  • O,P'-DDD, 250MG, NEAT
  • 2,4'-DDD, 1000MG, NEAT
  • 1-(2-CHLOROPHENYL)-1-(4-CHLOROPHENYL)-2, 2-DICHLOROETHANE, 99+%
  • 1-(2-CHLOROPHENYL)-1-(4-CHLOROPHENYL)-2,2-DICHLOROETHANE (2,4'-DDD)
  • Peprin
  • o,p'-DDD, CB-313, Lysodren, 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane
  • 1,1-dichloro-2-(2-chlorophenyl)-2-(4-chlorophenyl)ethane solution
  • 2,4'-ddd solution
  • 2-(p-Chlorophenyl)-2-(o-chlorophenyl)-1,1-dichloroethane
  • Benzene, 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]- (9CI)
  • Ethane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)- (6CI, 7CI, 8CI)
  • Lysordren
  • 1-chloro-4-[2,2-dichloro-1-(2-chlorophenyl)ethyl]benzene
  • 2,4'-DDD (=TDE)
  • o.p'-DDD 250mg [53-19-0]
  • 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane,(2,4′-Dichlorodiphenyl)dichloroethane, o,p′-DDD, Mitotane
  • Mitotane (500 mg)
  • o,p'-DDD [2,4'-Dichlorodiphenyldichloroethane]
  • Mitotane, USP
  • Mitotane (Lysodren)
  • (2,4μ-Dichlorodiphenyl)dichloroethane, 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane, o,pμ-DDD, Mitotane
  • (2,4μ-Dichlorodiphenyl)dichloroethane, o,pμ-DDD, Mitotane
  • 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)-benzen
  • 2-(o-chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloro-ethan
Copyright 2019 © ChemicalBook. All rights reserved